Salim Soyinka LO's Flashcards

1
Q

What is rheumatic fever (ARF)?

A

Delayed inflammatory complication of group A beta streptococcal pharyngitis that usually occur within 2-4 weeks of acute infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the epidemiology of Acute rheumatic fever?

A
  • Peak incidence 5-15 years

- more prevalent in resources limited countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the causes (aetiology) of rheumatic fever?

A
  • Previous infection with group A beta hemolytic streptococcus (GAS) also referred to as streptococcus pyogenes
  • usually acute tonsilitis or pharyngitis (strep throat)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical feature of ARF

A
  • Fever
  • malaise
  • fatigue
  • migratory polyarthritis
  • Pancarditis (endocarditis, myocarditis, pericarditis)
  • Valvular
  • Sydenham chorea
  • Subcutaneous nodules
  • Erythema marginatum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pancarditis

A
  • rare condition with a poor prognosis combining endocarditis, myocarditis with abscess formation and purulent pericarditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Endocarditis

A
  • rare and potentially fatal inflammation of the inner lining of the heart chambers and valves and is usually caused by bacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Myocarditis

A
  • Inflammation of heart muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pericarditis

A
  • inflammation of the pericardium/ thin sac that surrounds the heart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

High pressure valves

A
  • aortic

- mitral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mitral valve and ARF

A
  • 65 % of cases
  • early mitral regurgitation
  • late mitral stenosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most common cause of mitral stenosis

A

Rheumatic fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aortic valve and arf

A
  • 25 % of cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tricuspid valve and ARF

A
  • 10% of cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Sydenham chorea

A
  • involuntary, irregular, nonrepetitive movements of the limbs, neck, head and/or face
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical features sydenham chorea

A
  • 1-8 months after infection
  • sometimes asymmetrical or confined to one side
  • speech disorders
  • ballismus
  • muscle weakness
  • neuropsychiatric symptoms ( inappropriate laughing/crying, agitation, anxiety, apathy, OCD behaviour)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ballismus

A
  • severe movement disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pathophysiology of sydenham chorea

A
  • streptococcal antigens lead to Ab production–> Abs cross-react with structures of the basal ganglia and cortical structures –> reversible dysfunction of cortical and striatal circuits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Erythema marginatum

A
  • expanding pink or light rash with a well defined outer border and central clearing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

JONES criteria for diagnosis rheumatic fever

A
  • Joints
  • Pancarditis
  • Nodules
  • Erythema marginatum
  • Sydenham chorea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pathophysiology ARF

A
  • Exact pathogenesis not entirely understood but most common
  • Acute tonsilitis/ pharyngitis caused by GAS without antibiotic treatment –> development of antibodies against streptococcal M protein–> cross reaction of antibodies with nerve and myocardial proteins (most commonly myosins) due to molecular mimicry–> type II hypersensitivity reaction –> acute inflammatory sequela
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Molecular mimicry

A
  • similarities between foreign and self-peptides favor an activation of autoreactive T or B cells by a foreign derived antigen in a susceptible individual
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pathology of ARF

A
  • Aschoff bodies

- Anitschkow cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Aschoff bodies

A
  • nodules found in the hearts of individuals with rheumatic fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Anitschkow cells

A
  • cardiac histiocytes appearing in Aschoff bodies

- ovoid nucleus containing wavy, caterpillar like bar of chromatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Histiocytes

A
  • macrophages found in tissue not in blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Investigations for ARF

A
  • Full blood counts (leukocytosis)
  • May show normochromic normocytic anemia of chronic inflammation
  • Elevated CRP/ESR
  • Tests to show recent GAS infection ( increased antistreptolysin O titer and antistreptococcal DNAse B titer
  • Positive throat culture
  • Positive rapid GAS carbohydrate antigen detection test
  • Confirmed ARF: ECG and echocardiogram
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Prognosis ARF

A
  • ## Early death due to myocarditis rather than valvular defects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Advantages of antibiotic prophylaxis

A
  • non-invasive method of preventing future medical issues/infections eg at surgical site infection
  • Prevention of bacteremia (spread of bacteria to blood)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Disadvantages of antibiotic prophylaxis

A
  • Resistance: bacteria become resistant to the low dose of antibiotics over time so that the antibiotics are no longer effective
  • Cost of therapy can be high
  • Abuse by public and GP’s
  • Toxicity and adverse reactions
  • Interactions with other drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Why would additional antibiotics be needed to during surgery/dentistry in rheumatic heart disease?

A
  • commensals can be introduced into bloodstream
  • Harmless for most people but in those. with rheumatic heart disease bacteria can settle on damage endocardium and become surrounded by platelets and fiblin and begin to destroy heart valves
  • Phagocytes cannot reach through due to protective fibrin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Why are prophylaxis antibiotics stopped in adulthood?

A
  • Adults less likely to get streptococcal throat infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Why are prophylaxis antibiotics given in rheumatic fever?

A
  • Patients with RF have a higher incidence of recurrent s.pyogenes infection than others and each new episode causes a new episode of RF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Drugs affecting bacterial cell wall

A
  • Beta lactams (penicillins, cephalosporins, monobactams, carbapenems)
  • Glycopeptides
  • Cyclic lipopeptides
  • Polymixins
  • Phosphoric acid derivatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

MOA beta lactams (ring)

A
  • bind to penicillin binding proteins (PBP)/ transpeptidation enzymes
  • Inhibits the transpeptidases (cannot cross link peptide chains) and cell cannot maintain its transmembrane osmotic gradient
  • cell swelling rupture and death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

MOA glycopeptides

vancomycin

A
  • Binds to D-Ala-D-Ala sequence on peptide chain preventing peptidoglycan polymerase from binding single subunits to form a peptidoglycan chain
  • Transpeptidation is also inhibited
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

MOA cyclic lipopeptides

daptomycin

A
  • lipophilic tail of daptomycin is inserted into the bacteial cell membrane
  • Causing rapid membrane depolarisation and potassium ion efflux
  • DNA, RNA and protein synthesis are inhibited and cell death occurs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

MOA polymixins

colistin: polymixin E, polymixin B

A
  • initial target is LPS of outer membrane
  • bind to phospholipid in OM leading to cell membrane permeability changes, osmotic barrier lost and cell death occurs due to leakage of cell content
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

MOA phosphoric acid derivatives

fosfomycin

A
  • Taken into bacterial cell and inhibits synthesis of peptidoglycan by blocking the formation of NAM disrupting cell wall synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

List drugs affecting bacterial DNA

A
  • Quinolones
  • Nitroimidazole
  • Nitrofuran
  • Sulphonamides
  • Diaminopyrimidines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Quinolones MOA and eg

A
  • Ciprofloxacin, moxifloxacin, levofloxacin
  • inhibit DNA gyrase and topoisomerase IV
  • Gyrase introduces negative superhelical twists in the bacterial DNA diuble helix
  • Topoisomerase IV: responsible for segregating newly formed DNA into two new chromosomes
41
Q

Nitroimidazole MOA and eg

A
  • metronidazole
  • converted to a toxic metabolite by an oxidoreductase enzyme
  • Active against anaeobic bacteria as they possess the oxidoreductase enzyme
  • Toxic metabolite acts as an electron acceptor (reduced)
  • Resulting free radical intermediates damage DNA
  • Bactericidal
42
Q

Nitrofuran MOA and example

A
  • eg nitrofurantoin
  • reduced by nitrofuran reductase to unstable reactive metabolites which disrupt ribosomal RNA, DNA and other cell processes
  • Bactericidal
43
Q

Sulphonamides MOA and example

A
  • Sulfamethoxazole

- structurally similar to PABA and inhibits enzyme dihydropteroate synthetase

44
Q

PABA

A

bacteria use PABA to synthesise folate to manufacture purines in folic acid pathway

45
Q

Diaminopyrimidines MOA and example

A
  • Trimethoprim

- Inhibition of dihydrofolate reductase

46
Q

Co-trimoxazole

A
  • Sulfamethoxazole and trimethoprim
47
Q

Drugs affecting protein synthesis

A
  • Macrolides
  • Aminoglycosides
  • Tetracyclines
  • Glycylcycline
  • Amphenicols
  • Lincosamides
  • Fusidane
  • Oxazolidinones
48
Q

Bacterial ribosome

A

70s (30s and 50s)

49
Q

Macrolides MOA and example

A
  • azithromycin, clarithromycin, erythromycin
  • inhibit RNA-dependent protein synthesis by binding reversibly to the 50s subunit
  • Binding inhibits translocation of the peptide chain from the acceptor site (A) to the P site (donor site) blocking protein synthesis
  • bacteriostatic
50
Q

Lincosamides MOA and example

A
  • Clindamycin

- Binds 50s subunit, similar to macrolides

51
Q

Amphenicols MOA and eg

A
  • chloramphenicol

- Binds reversibly to 50s subunit and inhibit peptide bond formation preventing elongation of the peptide chain

52
Q

Oxazolidinones MOA and eg

A
  • linezolid

- Bind to 50s ribosomal subunit and prevent initiation of tRNA transcription

53
Q

Aminoglycosides MOA and eg

A
  • Gentamicin, tobramycin, amikacin
  • bind irreversibly to the 30s ribosomal subunit inhibiting translation from mRNA to protein, also cause misreading of mRNA
  • Bactericidal
54
Q

Tetracyclines MOA and eg

A
  • tetracycline, minocycline, doxycycline
  • bind reversibly to 30s subunit and block tRNA binding to the A site on the mRNA ribosome complex
  • bacteriostatic
55
Q

Glycylcycline MOA and eg

A
  • tigecycline
  • bind reversibly to 30s subunit and block tRNA binding to the A site on the mRNA ribosome complex (same as tetracyclines)
56
Q

Fusidane MOA and eg

A
  • fusidic acid
  • inhibits protein synthesis by preventing the translocation of elongation factor G from the ribosome
  • Elongation factor G is a catalyst for the translocation of tRNA and mRNA down the ribosome
  • bactericidal
57
Q

Risk factors for acute rheumatic fever

A
  • Age 5-14 –> initial episodes rare in older teens and young adults
  • Family hx: HLA class II genes appear to be strongly associated
  • certain strains of group A strep are more likely to contribute ( serotypes)
  • Environmental: crowding, poor hygiene lead to rapid transmission of strep
58
Q

Medical options in treatment of valvular heart disease

A
  • prophalyaxis antibiotics
  • Regular check ups at the dentist
  • Antibiotics during any surgical/dental procedures
  • Diuretics ( excess fluid)
  • ACE inhibitors (BP)
  • Antiarrythmic medications
  • Vasodilators
  • Beta blockers (BP)
  • Antithrombotic drugs
  • Anticoagulants
59
Q

Surgical options in treatment of valvular heart disease

A
  • Valve reconstruction (annuloplasty)
  • Valve replacement
  • Percutaneous balloon valvuloplasty for stenosis (balloon in stenotic valve to widen)
60
Q

Types of valve replacement and advantages/disadvantages

A
  • biological: anticoagulants only needed for 3 months but 10 year life span
  • prosthetic: life long span but anticoagulants always needed
61
Q

Antibiotics used for GAS infection

A
  • first line penicillin V

- cephalosporins or macrolides if penicillin allergy

62
Q

Rheumatic heart disease vs infective endocarditis

A
  • infective endocarditis: infection of the endocardium that typically affects one or more heart valves, usually a result of bacteremia, which is most commonly caused by dental procedures, surgery, distant primary infections, and nonsterile injections
  • Rheumatic heart disease:: does not involve bacterial infection, heart valves have been left damaged by rheumatic fever and are susceptible to bacterial infection
63
Q

What does left sternal edge heave indicate?

A
  • heel of hand lifted off chest during each systole

- Aortic stenosis

64
Q

Aetiology of infective endocarditis

A
  • Staphylococcus aureus: 35-45% IE cases, drug users, prosthetic valves, pacemakers
  • Viridans streptococci: 20% cases, most common cause subacute IE especially in predamaged native valves (mitral), dental procedures, produce dextrans which facilitate binding of fibrin-platelet aggregates on heart valves
  • Staphylococcus epidermis: less than 15% of cases, bacteremia from infected peripheral venous catheters, subacute IE in patients with prosthetic heart valves, pacemakers, ICD’s
  • Enterococci (especially enterococcus faecalis): 10%, multiple drug resistance, cause of IE after nosocomial UTI’s. native and prosthetic valves IE
  • Streptococcus gallolyticus: less than 10% cases, colorectal cancer
  • GRAM negative HACEK group: less than 5% of cases, poor dental hygiene/peridontal infection
  • Fungal endocarditis ( candida, aspergillus fumigatus): less than 5%, immunosuppressed patients, IV drug abusers, cardiosurgical interventions, long-dwelling IV catheters
  • Coxiella burnetii Bartonella species: less than 5% of native valve IE cases, Gram-negative pathogens responsible for culture-negative endocarditis
65
Q

Pathology of infective endocarditis

A
  1. Damaged valvular endothelium–> exposure of the subendothelial layer–> adherence of platelets and fibrin–> sterile vegetation (microthrombus)
  2. localised infection or contamination –> bacteremia–> bacterial colonization of vegetation–> formation of fibrin clots encasing the vegetation–> valve destruction with loss of function
66
Q

Valves involved in infective endocarditis (in order most frequent)

A
  • mitral
  • aortic
  • tricuspid (most common IV drug users)
  • pulmonary
67
Q

Clinical consequences of IE

A
  1. bacterial vegetation–> bacterial thromboemboli–> vessel occlusion–> infarctions
  2. emboli can lead to metatstatic infections of other organs
  3. formation of immune complexes and antibodies against tissue antigens –> glomerulonephritis, oslers nodes
68
Q

Atrial septation

A
  • septum primum forms and extends down towards endocardial cushions to split atria in 2
  • ostium/foramen primum is a hole present before septum primum completes fusion with endocardial cushions
  • before ostium primum closes, ostium secondum appears within septum primum
  • septum secondum grows with a hole known as foramen ovale present
  • presence of ostium secondum and foramen ovale allows a right to left shunt to be present in developing heart
69
Q

Ventricular septation

A
  • muscular ventricular septum grows up from the floor of ventricles towards fused endocardial cushions
  • small gap in interventricular septum remains which i filled with membranous portion of ventricle
70
Q

Heart formation

A
  • Blood islands condenses to form 2 heart tubes
  • lateral folding to form primitive heart tube
  • Sinus venosus: RA
  • primitive atrium
  • primitive ventricle: left ventricle
  • bulbus cordis: right ventricle
  • truncus arteriosis : ascending aorta and pulmonary trunk
  • cardiac looping
71
Q

LaPlace law (heart work and mural tension)

A
T= PR/2
T= wall tension
P= pressure
R= radius 
- dilation: increased radius, T has to rise to generate given pressure in systole 
S= Pr/2h
S=stress, 2h wall thickness 

Dilated ventricle: increased radius, muscle stretched thin, stress increases more than tension

Ventricular stretch makes AV valves incompetent as papillary muscles and chordae tendinae no longer span gap between ventricular walls and mitral and tricuspid valves
Blood is forced back into atria, squanders part of cardiac work
Leaky valves and undue stress on ventricular muscle mean that beyond a certain point, rises in cardiac pressure are self- defeating

72
Q

Starlings Law of the heart (normal and failing ventricle)

A
  • stroke volume of left ventricle will increase as the left ventricular volume increases due to myocyte causing a more forceful systolic contraction
73
Q

S2

A
  • closure of aortic and pulmonary valves
  • higher pitch and shorter than S1
  • beginning of diastole
74
Q

S3

A
  • can be normal in some people but can also be pathogenic
  • low pitch
  • mid diastolic
  • gallop rhythm
75
Q

S4

A
  • always pathological
  • late diastolic
  • higher pitch than S3
76
Q

Stenosis

A

narrowing of vessel/valve

77
Q

Regurgitation

A

backflow of blood

78
Q

systolic murmur

A
  • ASMR
  • Aortic stenosis
  • Mitral regurgitation
  • pulmonic stenosis
  • atrial septal defect
  • tricuspid regurgitation
  • VSD
  • mitral valve prolapse
79
Q

diastolic murmur

A
  • Aortic regurgitation

- Mitral stenosis

80
Q

diastolic murmur

A
  • Aortic regurgitation
  • Mitral stenosis
  • pulmonic regurgitation
  • tricuspid stenosis
  • patent ductus arteriosus
81
Q

aortic stenosis

A

mid systolic

crescendo-decrescendo

82
Q

Mitral regurgitation

A

holosystolic
high pitch
blowing

83
Q

Aortic regurgitation

A

early diastolic
high pitch
blowing
crescendo

84
Q

Mitral stenosis

A

mid-late diastolic
opening snap
rumbling

85
Q

how are murmurs graded

A

1-5 where 1 is very faint and 5 is very loud, may be heart with stethoscope entirely off chest

86
Q

P wave

A

atrial depolarisation

0.12 seconds

87
Q

QRS wave

A

ventricular depolarisation

less than 0.12 sec

88
Q

ST segment

A

plateau phase of depolarisation

89
Q

PR

A

Transmission of signal from atria to ventricles
0.12 to 0.2
Prolonged blockage
Shortened: extra tissue

90
Q

T wave

A

Rapid ventricular repolarisation

91
Q

QT wave

A

hypo/hyperkalemia

92
Q

look at pic of cardiac cycle combination

A
93
Q

Calculate axis of heart –> see notes

A
94
Q

Warfarin

A
  • Vitamin K is a cofactor for gamma-carboxylation of glutamic acid, which is essential for proper function of coagulation factors II, VII, IX, X.
  • Vitamin K is reduced by epoxide reductase and in its reduced form acts as a cofactor for carboxylation.
  • Warfarin inhibits expoxide reductase, preventing vitamin K from acting as a cofactor
  • Is slow acting, takes about 2-5 days to work and is used for chronic anti-coagulation
  • AE – teratogenic, bleeding, skin necrosis, drug-drug interactions
95
Q

Heparin

A
  • Antithrombin III typically inactivates thrombin and factor Xa, but the process is slow
  • Heparin is a long sugar that will bind both ATIII and thrombin, or ATIII and Xa, to increase the speed at which ATIII inhibits these coagulation factors.
  • prothrombin to thrombin and fibrinogen to fibrin inhibited
96
Q

Unfractionated vs LMW heparin

A
  • LMWH Xa activity

- unfractionated Xa and IIa activity

97
Q

Dabigatran

A

Direct thrombin inhibitor

98
Q

Rivaroxaban

A

Direct Xa inhibitor